🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the switch from Nivolumab Intraven...
Status
Withdrawn
Location
Local Institution - 0020
Start Date
2023-05-31
Trial ID
NCT05496192
Treatments Being Tested
A study evaluating the drug levels of ipilimumab alone and in combination w...
Status
Terminated
Location
Local Institution - 0020
Start Date
2020-06-25
Trial ID
NCT04311710
Treatments Being Tested
The purpose of this study is to demonstrate that the study drug exposure le...
Status
Active Not Recruiting
Location
Local Institution - 0125
Start Date
2023-03-06
Trial ID
NCT05625399
Treatments Being Tested
The purpose of this study is to assess the safety and tolerability of subcu...
Status
Completed
Location
Local Institution - 0004
Start Date
2022-08-02
Trial ID
NCT05297565
Treatments Being Tested
The purpose of this study is to evaluate the drug levels, efficacy, safety,...
Status
Active Not Recruiting
Location
Local Institution
Start Date
2021-05-21
Trial ID
NCT04810078
Treatments Being Tested
This study will characterize the movement of drugs within the body, evaluat...
Status
Completed
Location
Local Institution - 0001
Start Date
2019-10-01
Trial ID
NCT04112498
Treatments Being Tested
The purpose of this study is to test the safety and efficacy of BMS-986482 ...
Status
Recruiting
Location
University of California, Irvine (UCI) Health - UC Irvine Medical Center
Start Date
2025-02-17
Trial ID
NCT06697197
Treatments Being Tested
The purpose of this study is to investigate the effects of nivolumab when g...
Status
Completed
Location
Winship Cancer Institute.
Start Date
2018-10-29
Trial ID
NCT03656718
The purpose of this study is to assess the patient's preference for nivolum...
Status
Active Not Recruiting
Location
Local Institution - 0007
Start Date
2023-11-06
Trial ID
NCT06101134
Treatments Being Tested
This phase III trial compares the effect of adding live biotherapy, MO-03, ...
Status
Recruiting
Location
Highlands Oncology Group - Fayetteville
Start Date
2026-06-05
Trial ID
NCT07383441